UNLOCKING RESEARCH: Health System Improvement

Through Ef fect ive Implementat ion

Implementat ion Science Symposium 2018

Our partners

About Sydney Health Partners

In 2015 Sydney Health Partners was accredited by the National Health and Medical Research Council as an Advanced Health Research and Translation Centre – recognition of our members’ world-leading use of research to improve health care and health outcomes.

Our partnership is made up of the Sydney, Northern Sydney and Western Sydney Local Health Districts; the Sydney Children’s Hospitals Network (at Westmead), the University of Sydney and nine of their affiliated independent medical research institutes.

Our unique advantages rest in the strong leadership of our Local Health Districts, a long history of successful collaboration in research between the University and research institutes, and our scale of operation.

Together we aim to accelerate the transfer of research innovations into health care improvements.

We are taking steps to enable the sharing and use of data, support ethics and governance, enable greater access and use

of biobanks, increase consumer and community involvement in research, support access to clinical trials infrastructure, and foster the discipline of implementation science to facilitate change.

In addition we currently support 14 Rapid Applied Research Translation projects with grants funded by the Medical Research Future Fund. Each of these projects aims to prove a medical research-based intervention in a clinical setting.

Sydney Health Partners also aims to overcome barriers to collaboration between researchers and clinicians. Our partnership-wide research streams and cross-cutting themes bring together cross-disciplinary teams to solve health system problems.

1

Welcome

The value of health and medical research to Australia has probably never been more widely appreciated. Politicians and the community generally understand that money spent on research today will save much more from needing to be spent on health care tomorrow.

The Medical Research Future Fund is starting to offer significant new funding opportunities to researchers and, in recent years, the investment of governments has contributed to the opening of several impressive new research facilities across Australia.

Now, as health care systems face increasing demands and resource constraints, it has become important that we deliver more quickly on the investment and support for the sector.

Regrettably, the 17 year average to translate a discovery into clinical practice is reducing only very slowly. The uptake of new interventions is not spontaneous, and implementation is often done incompletely, inconsistently and with limited effectiveness.

Sydney Health Partners is focussed on delivering the benefits of health research and innovation to our patients and communities faster and more efficiently. We believe that the application of implementation science has the potential to reduce or remove some of the barriers to effective research translation.

Since our first symposium in 2017, interest in this relatively new field has snowballed. That increased momentum is reflected in a much larger program for the 2018 Symposium and subsequent events, which now cover four days and feature national and international leaders in the field.

It is hoped that this program of activities will build knowledge and capacity in implementation science across our Partnership and beyond, demonstrating that collaborative translational research can be successfully applied in a large, diverse health system.

Professor Garry Jennings AOExecutive Director Sydney Health Partners

2

What is Implementation Science?

Implementation science is the scientific study of methods to promote the systematic uptake of evidence-based practices into routine clinical practice, and, hence, to improve the quality and effectiveness of health services and care.

As a new discipline, implementation science broadly focuses on the ‘how’ questions: How do we get evidence to drive practice and get evidence-based interventions to become standard care so that everyone who can benefit from them has access?

Implementation science studies typically seek to implement an evidence-based practice, program or intervention in a setting using defined strategies, and study how this can be upscaled across health services.

Such studies typically employ mixed quantitative-qualitative designs, identifying factors that impact uptake across multiple levels, including patient, provider, clinic, facility, organisation, and often the broader community and policy environment.

It requires the collaboration of trans-disciplinary research teams that include health professionals, health services researchers; behavioural scientists and psychologists, economists; sociologists; operational partners such as managers, administrators, as well as patients and community representatives.

While it shares some characteristics with quality improvement and dissemination research, implementation science also seeks to develop generalizable knowledge that can be widely applied beyond the particular system under study.

3

19th November

8:30 – 8:55am Registration

8:55 – 9:15am Introduction• Professor Garry Jennings AO, Sydney Health Partners

Acknowledgement of Country• Professor Lisa Jackson Pulver AM, University of Sydney

Introduction to keynote speaker, Professor Anne Sales• Dr Nicole Rankin, Sydney Health Partners, Cancer Council

NSW and University of Sydney

SESSION 1 - CHAIR: PROFESSOR GARRY JENNINGS AO, SYDNEY HEALTH PARTNERS

9:15 – 10:00am Keynote presentation: Implementation Science: How it can support health research• Professor Anne Sales, University of Michigan

10:00 – 10:30am Panel discussion: Why do health interventions sometime fail?• Dr Michael Brydon, Sydney Children’s Hospitals Network• Professor Adam Elshaug, University of Sydney • Professor David Hunter, University of Sydney, Northern

Sydney Local Health District • Professor Anne Sales, University of Michigan

10:30 – 11:15am Morning tea

SESSION 2 – CHAIR: PROFESSOR TIM SHAW, THE UNIVERSITY OF SYDNEY

11:15 - 11:35am Presentation: Convergence: experience, technology and data• Mr. Evan Rawstron, KPMG

11:35am – 12:05pm Presentation: Insights from an industry research foundation• Associate Professor Annette Schmiede,

Bupa Health Foundation

12:05 – 12:45pm Panel discussion: Engaging the expertise of our partners in industry to implement health system change • Ms. Georgina Drury, Springday• Associate Professor Jim Gillespie, University of Sydney• Professor Ron Grunstein, Woolcock Institute of Medical

Research, University of Sydney, Sydney Local Health District• Mr. Evan Rawstron, KPMG• Associate Professor Annette Schmiede,

Bupa Health Foundation

Program

4

12.45 – 2:05pm Lunch

SESSION 3 – CHAIR: PROFESSOR JANE YOUNG, THE UNIVERSITY OF SYDNEY

2:05 – 2:25pm Presentation: Implementing population health interventions at scale: lessons from the field• Associate Professor Andrew Milat, NSW Ministry of Health

2:25 – 2:45pm Presentation: Implementing models for Hep C elimination• Professor Jacob George, The Westmead Institute for Medical

Research, University of Sydney, Western Sydney Local Health District

2:45 – 3:30pm Panel discussion: Upscaling interventions – how can we drive change through large scale efforts? • Professor Jennifer Alison, University of Sydney,

Sydney Local Health District • Dr Teresa Anderson AM, Sydney Local Health District • Professor Jacob George, The Westmead Institute for Medical

Research, University of Sydney, Western Sydney Local Health District

• Associate Professor Andrew Milat, NSW Ministry of Health • Professor Don Nutbeam, Sydney Health Partners and

University of Sydney

3:30 – 4:00pm Afternoon tea

SESSION 4 - CHAIR: PROFESSOR LAURENT RIVORY, THE UNIVERSITY OF SYDNEY

4:00 – 4:40pm Panel discussion: Where to next for implementation and dissemination?• Professor David Peiris, The George Institute for Global Health • Dr Nicole Rankin, Cancer Council NSW and Sydney

Health  Partners • Professor Anne Sales, University of Michigan • Ms. Deborah Willcox, Northern Sydney Local Health District

4.40 – 4:45pm Closing remarks• Professor Garry Jennings AO, Sydney Health Partners

4:45 – 5:45pm Cocktail function

5

Our presenters and chairs

Professor Garry Jennings AO Executive Director, Sydney Health Partners

Professor Garry Jennings AO is the Executive Director of Sydney Health Partners and has extensive experience in health and medical research, specialising in cardiology. He served as the Director of Baker IDI Heart and Diabetes Institute in Melbourne for 14 years and most recently as the Interim CEO of the National Heart Foundation. He has had a long association with the National Heart Foundation as a former Board Member and Chair of its Cardiovascular Health Advisory Committee.

As a leading cardiologist, Professor Jennings has also had a long career in clinical practice including as the Director of Cardiology at The Alfred Hospital, Melbourne. Professor Jennings also played a key role in the transformation of The Alfred campus as Foundation Chair of the Alfred Medical Research and Education precinct. As a researcher, his interests include the prevention and treatment of cardiovascular disease.

Professor Jennings was appointed an Officer of the Order of Australia in 2013 for his service to medical research and the prevention and control of cardiovascular disease, obesity and diabetes.

6

Dr Nicole Rankin Senior Research Fellow, Sydney Health Partners, Cancer Council NSW and The University of Sydney

Dr Nicole Rankin is an implementation scientist and Senior Research Fellow at Cancer Council NSW in lung cancer, and Senior Research Fellow in Implementation Science, University of Sydney. In 2016, Nicole commenced a two-year fellowship in the Mentored Training in Dissemination and Implementation Research in Cancer (MT-DIRC) program at Washington University in St Louis.

Nicole’s background is behavioural science, psycho-oncology, qualitative research and the translation of evidence into practice and policy. She has extensive experience in cancer control, including translation of evidence into practice and policy and is leading research projects to improve lung cancer outcomes, focused on primary care and early detection, as well as cancer survivorship.

Professor Anne Sales Associate Chair, Educational Programs and Health System Innovation, University of Michigan

Professor Sales is a Professor and the Associate Chair for Educational Programs and Health System Innovation in the Department of Learning Health Sciences, University of Michigan Medical School. She is also a Research Scientist at the Center for Clinical Management Research at the VA Ann Arbor Healthcare System. Her training is in sociology, health economics, econometrics, and general health services research.

Professor Sales' current work involves theory-based design of implementation interventions, including understanding how feedback reports affect provider behaviour and through behaviour change have an impact on patient outcomes, and the role of social networks in uptake of evidence based practices and implementation interventions. She has completed over 30 funded research projects, including a Partnered Evaluation Initiative funded by the VA Office of Nursing Services, evaluating the 7

Tim has an active research and development group at the University of Sydney with 8 PhDs, 3 Postdoctoral Fellows and 5 Research and administrative staff. He combines his experience as an implementation scientist with a deep understanding of the role of technology in health system transformation. With over 70 publications and having been CI on over 20 grants and consultancies totalling over $124M in the last 5 years, Tim’s focus is on working at the coal-face of service delivery to implement innovations in health and healthcare.

Evan Rawstron Lead Partner for the NSW Health Economy, KPMG

Evan Rawstron is a trusted adviser to a wide range of organisations within Australia’s largest health system and has also advised a range of governments, not-for-profit and private health care organisations throughout Australia. In addition to his work within Australia, Evan leads KPMG’s global health analytics network with more than a dozen contributing countries, as well as KPMG’s national capability for Patient Experience.

implementation and effectiveness of VA national nursing initiatives, and currently leads a VA Quality Enhancement Research Initiative Program focused on implementing goals of care conversations in VA long term care settings.

Professor Sales is co-Editor-in-Chief of Implementation Science, together with Michel Wensing of Heidelberg University in Germany.

Professor Tim Shaw Director, Research in Implementation Science and eHealth Team (RISe), The University of Sydney

Professor Shaw is the inaugural Professor of eHealth and Director of the Research in Implementation Science and eHealth Team (RISe) in the Faculty of Health Sciences at the University of Sydney and he is Director of Research in the recently funded 7 year $112M Digital Health Cooperative Research Centre (CRC). The CRC brings together academia, industry, government and service providers to transform care through technology.

8

Before joining KPMG, Evan held senior executive roles in the private hospital sector, the higher education sector, and in the NSW Health public system. Evan has postgraduate qualifications in Health Administration from the University of NSW and International Health Policy and Health Economics from the London School of Economics, where he graduated with distinction and won the Brian Abel-Smith prize.

Associate Professor Annette Schmiede Executive Leader, Bupa Health Foundation

Annette Schmiede has worked in Australia’s health and aged care sectors for over three decades. She has a broad knowledge and deep understanding of the complex policy issues facing the provision of these services. Her working experience includes health services research, health service planning, governance and policy development.

Annette has had advisory and leadership roles across a range of public, private and non- government organizations and has an

established reputation for managing complex hospital development projects procured through public private partnerships.

An economics graduate of the University of Sydney, Annette completed a year as a Visiting Fellow at the Centre for Clinical Governance Research in Health at the UNSW in 2003. She is an adjunct associate professor with the School of Public Health at the University of Sydney and an associate of the Menzies Centre for Health Policy. Her research interests include mental health, clinical governance, health system reform and innovation.

Professor Jane YoungProfessor of Cancer Epidemiology, The University of Sydney, Sydney Local Health District

Jane Young is Professor in Cancer Epidemiology at the University of Sydney and leads the Cancer Epidemiology and Services Research (CESR) group within the Sydney School of Public Health and has an advisory role as Scientific Director of the Cancer Institute NSW (CINSW).

9

Since 2002, she has been the Executive Director of the Surgical Outcomes Research Centre (SOuRCe), a conjoint multidisciplinary research unit of Sydney Local Health District and the University of Sydney. Jane’s research focuses on the application of epidemiological methods to improve cancer services and outcomes, the evaluation of surgical outcomes, the promotion of evidence based practice and the use of data to improve cancer service delivery.

Associate Professor Andrew Milat Director, Evidence and Evaluation, NSW Ministry of Health

Andrew Milat is Director, Evidence and Evaluation at the New South Wales Ministry of Health and is an Adjunct Associate Professor in the Sydney Medical School, University of Sydney. His PhD focused on implementation science and scale up of health interventions.

In his current role Andrew is responsible for strategic research and evaluation support services within the Ministry - facilitating the generation and use of high-quality

population health evidence, communicating and disseminating research evidence and supporting the development of a skilled and sustainable population health workforce through the four Population Health Training Programs.

Andrew has held positions including the Head of the Knowledge Transfer Division at the Sax Institute, Research Manager with the Australian Government Department of Health and regional Director of Health Promotion.

Professor Jacob George The Westmead Institute for Medical Research, University of Sydney, Western Sydney Local Health District

Jacob George is the Robert W. Storr Professor of Hepatic Medicine at the Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Head of the Department of Gastroenterology and Hepatology at Westmead Hospital. He undertakes basic and clinical research on NASH, hepatitis C, liver cancer and hepatic fibrosis.

10

Professor George is an Associate Editor for the Journal of Hepatology, and is or has been on the Editorial Board of Hepatology, Liver International, Hepatology International and the World Journal of Gastroenterology.

He was a past Executive Council member of the Asian Pacific Association for the Study of the Liver and was on the council of the Gastroenterological society of Australia. Professor George has published over 365 papers, with over 26,000 citations.

Professor Laurent Rivory Pro-Vice-Chancellor (Research), The University of Sydney

Professor Rivory has 20 years’ experience in research and leadership, which has spanned the higher education, hospital and industry sectors. He is widely recognised for his research in cancer drug pharmacology through appointments at the University of Queensland, the Royal Prince Alfred Hospital, the Université de Bordeaux II and the Fondation Bergonié, and the University of Sydney.

Professor Rivory also served as Senior Research Director, Research and Development, at Johnson and Johnson Research and was most recently Director of the Research Strategy Office at the University of New South Wales.

As PVC (Research), Professor Rivory’s responsibilities include the large-scale collaborations such as the Charles Perkins Centre and the Brain and Mind Centre, the Core Research Facilities and the management of external partnerships, particularly in health.

11

Acknowledgements

Sydney Health Partners and the University of Sydney would like to acknowledge everyone who contributed to the success of this event.

We would like to thank all the presenters and panellists for their enthusiasm and insights. Our special appreciation goes to keynote speakers Professor Anne Sales, Evan Rawstron, Associate Professor Annette Schmiede, Associate Professor Andrew Milat and Professor Jacob George – and to Dr Nicole Rankin, Professor Don Nutbeam and Professor Tim Shaw for their invaluable assistance in shaping the program.

We are also grateful for the ongoing support of our partner organisations and the many administrators, healthcare professionals and researchers who contribute to the Partnership.

For further information about Sydney Health Partners go to sydneyhealthpartners.org.au

12

Keynote speaker - Professor Anne Sales, University of Michigan

Sydney Health PartnersLevel 3, The Hub | Charles Perkins Centre (D17)

The University of Sydney NSW 2006T: +61 2 8627 5452

www.sydneyhealthpartners.org.au

19 NOVEMBER 2018Veter inary Science Conference Centre,

The Universi ty of Sydney

@SHPartners #ImpSymp